Vitality’s John Downes examines the history, variations, symptoms and underwriting considerations of Devic’s Disease.
Devic's Disease, also known as Neuromyelitis Optica (NMO) or Neuromyelitis Optica Spectrum Disorder (NMOSD), is an autoimmune condition where the immune system damages the spinal cord and the nerves in the eyes. Across Europe, its prevalence is thought be around one in 100,000, which translates to about 700 people in the UK. It occurs at any age, affecting women significantly more than men, and it may also be more prevalent in some ethnic groups, although it is not hereditary or infectious. Eugene Devic was a French physician who, in 1894, described a condition that he called an ‘acut...
To continue reading this article...
Join COVER for free
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.